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Background:  Pacemakers (PM) are capable of recording tachyarrhythmic events, including non-sustained ventricular tachycardia (NSVT). A finding 
of NSVT often elicits clinical evaluation, though its significance is unknown. We wished to evaluate the prognostic significance of NSVT noted on 
routine follow-up of PM patients.
Methods:  A single-center retrospective cohort study was performed on all patients followed for > 1 year in the PM Clinic at Northwestern 
University’s faculty practice from 2004-09 whose PM’s were capable of recording NSVT. NSVT was defined as ≥5 consecutive beats recorded on 
intracardiac electrocardiogram, with a rate of ≥175/minute lasting < 30 seconds. Patients were categorized as having: (1) NSVT when ventricular 
origin was confirmed; (2) no NSVT; (3) ventricular high rate episodes (VHR) when ventricular origin could not be determined with certainty. The 
primary endpoint was all cause mortality.
Results:  Of the 542 enrollees (51% male, 75±16 years), 130 had NSVT (24%), 330 (61%) had no NSVT and 82 (15%) had VHR. There was no 
significant difference in age, ejection fraction, prevalence of diabetes, hypertension, coronary artery disease, or beta blocker use between groups 
(p>0.05). During a mean follow up time of 5.3 years, there was no difference in median survival between groups (figure). 
Conclusion: NSVT noted on routine follow-up in PM patients does not affect long-term survival.
